Immunotherapy of leukemia and lymphoma.
D000951:Antigens, Neoplasm / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000302:isolation & purification / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008223:Lymphoma / Q000628:therapy*; D000432:Methanol; D009439:Neuraminidase / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000276:immunology; D012075:Remission, Spontaneous; D013997:Time Factors
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D009439:Neuraminidase; D000432:Methanol